Picture of Rani Therapeutics Holdings logo

RANI — Rani Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Rani Therapeutics Holdings Inc Reports Quarterly Loss Per Share Of $0.33

Nov 10 (Reuters) - Rani Therapeutics Holdings Inc
 RANI.O :
    * RANI THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * RANI THERAPEUTICS HOLDINGS - CASH, CASH EQUIVALENTS,
RESTRICTED
CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF SEPTEMBER 30,
2022 TOTALED $98.7 MILLION
    * QTRLY LOSS PER SHARE $0.33
    * Q3 EARNINGS PER SHARE VIEW $-0.47 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6w46pY 
Further company coverage:  RANI.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Rani Therapeutics Holdings

See all news